Skip to main content

Table 1 Changes in placebo-adjusted effectiveness outcomes for donepezil and memantine

From: Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation

Outcome

Donepezil

Memantine

Difference

MMSE (0-30)

1.16

0.48

-0.68

NPI (0-144)

-2.40

-2.76

-0.36

Function (0-100)

-4.44

-2.35

2.09

Relative Risk of Drop-Out

1.18

0.66

0.62